4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile
| Title | Journal |
|---|---|
| Crisaborole: Phosphodiesterase inhibitor for treatment of atopic dermatitis. | Drugs of today (Barcelona, Spain : 1998) 20170401 |
| Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults. | Journal of the American Academy of Dermatology 20160901 |
| Tolerability of Crisaborole Ointment for Application on Sensitive Skin Areas: A Randomized, Double-Blind, Vehicle-Controlled Study in Healthy Volunteers. | American journal of clinical dermatology 20160101 |
| A review of phosphodiesterase-inhibition and the potential role for phosphodiesterase 4-inhibitors in clinical dermatology. | Dermatology online journal 20140516 |
| Design and synthesis of boron-containing PDE4 inhibitors using soft-drug strategy for potential dermatologic anti-inflammatory application. | Bioorganic & medicinal chemistry letters 20100401 |
| Discovery and structure-activity study of a novel benzoxaborole anti-inflammatory agent (AN2728) for the potential topical treatment of psoriasis and atopic dermatitis. | Bioorganic & medicinal chemistry letters 20090415 |